BioCentury | Feb 9, 2015
Finance

Royalty replay

...NASDAQ:XOMA) received for autoimmune drug Cimzia certolizumab pegol; and undisclosed rights from transfusion products company Velico Medical Inc....
BioCentury | Sep 5, 2011
Finance

Equity into royalty

...2010, OrbiMed acquired royalty rights from private transfusion products company Velico Medical Inc. for an undisclosed sum. Velico...
BioCentury | Oct 1, 2009
Distillery Therapeutics

Indication: Hematology

...1, 2009 Patent pending covering compositions and methods for prolonging survival of platelets; licensed to Velico Medical Inc....
Items per page:
1 - 3 of 3
BioCentury | Feb 9, 2015
Finance

Royalty replay

...NASDAQ:XOMA) received for autoimmune drug Cimzia certolizumab pegol; and undisclosed rights from transfusion products company Velico Medical Inc....
BioCentury | Sep 5, 2011
Finance

Equity into royalty

...2010, OrbiMed acquired royalty rights from private transfusion products company Velico Medical Inc. for an undisclosed sum. Velico...
BioCentury | Oct 1, 2009
Distillery Therapeutics

Indication: Hematology

...1, 2009 Patent pending covering compositions and methods for prolonging survival of platelets; licensed to Velico Medical Inc....
Items per page:
1 - 3 of 3